One Health: White Tailed Deer

Last Modified: Marzo 08, 2024
Deer near forest

Between November 2021 and April 2022, APHIS, in collaboration with State and Tribal wildlife agencies, conducted surveillance for SARS-CoV-2 in wild white-tailed deer (Odocoileus virginianus). Thousands of respiratory and blood samples were collected from free-ranging white-tailed deer across 27 States.

Use the map below to learn how SARS-CoV-2 has impacted white-tailed deer by State.

SARS-CoV-2 in White-tailed Deer

In collaboration with its partners, APHIS is using a targeted multi-year surveillance approach to monitor and study wild cervid populations across the country. Conducting surveillance and research studies is helping APHIS to understand if cervids are acting as host or “reservoir species,” meaning if the virus survives in animals, which allows it to potentially mutate into new variants. APHIS aims to better understand the potential impacts of SARS-CoV-2 at the wildlife and human interface.

While experts are still learning about SARS-CoV-2 in animals, there is currently no evidence that animals play a significant role in spreading the virus to humans. However, since wildlife can carry multiple zoonotic diseases, even without looking sick, it is always important to enjoy wildlife from a distance. For more information, please contact: APHISpress@usda.gov.

This data, and all the information contained therein, have been collected by APHIS or its cooperators on APHIS’ behalf for restricted government purposes only and is the sole property of APHIS. See full disclaimer.

Other White-tailed Deer Studies

Information from the map above provides reference to these studies.

Stay Up to Date

Sign up for email or text updates for the latest news on One Health.

Subscribe